GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Defence Therapeutics Inc (XCNQ:DTC) » Definitions » Other Operating Expense

Defence Therapeutics (XCNQ:DTC) Other Operating Expense : C$0.29 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Defence Therapeutics Other Operating Expense?

Defence Therapeutics's Other Operating Expense for the three months ended in Dec. 2023 was C$0.15 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.29 Mil.

Defence Therapeutics's quarterly Other Operating Expense increased from Mar. 2023 (C$0.05 Mil) to Sep. 2023 (C$0.09 Mil) and increased from Sep. 2023 (C$0.09 Mil) to Dec. 2023 (C$0.15 Mil).

Defence Therapeutics's annual Other Operating Expense declined from Jun. 2020 (C$0.00 Mil) to Jun. 2021 (C$-0.00 Mil) but then increased from Jun. 2021 (C$-0.00 Mil) to Jun. 2022 (C$0.00 Mil).


Defence Therapeutics Other Operating Expense Historical Data

The historical data trend for Defence Therapeutics's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Defence Therapeutics Other Operating Expense Chart

Defence Therapeutics Annual Data
Trend Jun20 Jun21 Jun22
Other Operating Expense
- - -

Defence Therapeutics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 0.08 0.05 0.09 0.15

Defence Therapeutics Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.29 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Defence Therapeutics Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Defence Therapeutics's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Defence Therapeutics (XCNQ:DTC) Business Description

Traded in Other Exchanges
Address
200 Burrard Street, Suite 1680, Vancouver, BC, CAN, V6C3L6
Defence Therapeutics Inc is engaged in the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. The Company has one operating segment, being research and development.
Executives
Sarkis Meterissian Director